Glucocorticoids and β2-agonists regulate the pathologic metabolism of hyaluronic acid in COPD

Conclusions The combination of glucocorticoids with LABA counteracts the pathologic metabolism of HA in patients with COPD, suggesting an additional beneficial effect of the drugs when used for the treatment of COPD.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research